Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Alexion Encouraged By RNAi Developments, Partners With Dicerna

Oct 24 2018

• By Joseph Haas, Brian Yang, Jo Shorthouse, and Jung Won Shin

DealWatch_1200x675

Related Content

AbbVie To Take Flight From Galapagos As PELICAN Flounders?

Jun 29 2018

Alexion Continues Pipeline Rebuilding With $400m Takeout Of Syntimmune

Sep 26 2018

Innate Pharma's Expanded IO AstraZeneca Deal Jump-Starts US Ambitions

Oct 23 2018

Cerevel Launches With Pfizer's Early CNS Assets And $350m From Bain Capital

Oct 23 2018

Microbiome Offers Rich Pickings As Takeda Becomes Enterome's Second Big Pharma Crohn's Partner

Oct 23 2018

Related Companies

Alexion Pharmaceuticals Inc.

Dicerna Pharmaceuticals, Inc.

Blueprint Medicines Corporation

Arbutus Biopharma Corporation

Moderna, Inc.

Wilson Therapeutics AB

Syntimmune, Inc.

Complement Pharma

AbbVie Inc.

Galapagos NV

Vertex Pharmaceuticals Incorporated

Enterome SA

Takeda Pharmaceutical Co. Ltd.

Eyevance Pharmaceuticals LLC.

Novartis AG

Nicox S.A.

Focus Laboratories Inc.

InflammX Therapeutics, Inc

Purdue Pharma L.P.

HiFiBiO Therapeutics

HiFiBiO Therapeutics

Harbour BioMed

Harbour BioMed

Jiangsu Hengrui Pharmaceuticals

Pfizer Inc.

Innate Pharma S.A.

AstraZeneca PLC

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window